(PharmaNewsWire.Com, September 12, 2018 ) The Potential Non Invasive Prenatal Testing (NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021. Long–term Growth Projection: More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021. Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow at the CAGR of XX% during 2017-2021. Market growth can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). With increased patient access to NIPT test, the NIPT test market is anticipated to have a positive outlook in the coming years. High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of NIPT test market. NIPT Test Market: Test–wise Outlook Natera Panorama test will lead the NIPT test market with the market share of more than 25% by the year end of 2021. MaterniT21 Plus and Bambini test have shown its potential to become 2nd and 3rd popular NIPT test. Harmony test is the fourth leading test in the NIPT test market. NIFTY and Verifi test hold the fifth and sixth highest share of the NIPT test market. Other emerging tests such as Prena, IONA, VisibiliT, Veracity and informaseq NIPT test which is likely to affect the market share during the forecast period. NIPT Test Market: Country–wise Outlook: United States is the most attractive market with market share of more than 50% in 2016. China will be the second largest market for NIPT test which is expected to grow at a CAGR of XX% by 2021. United Kingdom is expected to be third largest NIPT test market being followed by Germany by the end of the forecasted period. This is the 3rd edition report on NIPT Test Market . The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, country wise actual and potential market, NIPT test analysis with volume and market revenue and competitive landscape. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SEGMENTATION Global Non-Invasive Prenatal Testing (NIPT) Market – By Test Type 1. MaterniT21 PLUS 2. Harmony 3. NIFTY 4. Verifi 5. Panorama 6. PrenaTest 7. BambniTest 8. informaSeq 9. VisibiliT 10. Veracity 11. IONA Test Global Non-Invasive Prenatal Testing (NIPT) Market – By Country 1. United States 2. United Kingdom 3. Germany 4. Italy 5. Spain 6. France 7. Switzerland 8. Sweden 9. Belgium 10. Australia 11. New Zealand 12. Japan 13. China 14. India 15. Brazil
If you have any special requirements, kindly Contact Us and we will offer you the report as you want.
About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
